Gapping down
In reaction to disappointing earnings/guidance:
- APHA -12.3% (also - to accelerate expiry of Green Growth Brands (GGBXF) bid and terminate option with GA Opportunities), ADNT -3.5%, GOGO -0.5%
Select metals/mining stocks trading lower:
- AU -2.2%, BHP -1%, GOLD -1%, GDX -0.9%, RIO -0.8%
Other news:
- ASMB -14.8% (presents interim results from two Phase 2a clinical trials of ABI-H0731 in HBV)
- APHA -12.1% (to accelerate expiry of Green Growth Brands (GGBXF) bid and terminate option with GA Opportunities)
- CLVS -11% (discontinuing its sponsored Phase 2 open-label monotherapy clinical trial evaluating rucaparib in recurrent, metastatic bladder cancer)
- ADS -3% (to sell Epsilon business to Publicis Groupe (PUBGY) for $4.4 bln in cash)
- MAT -2.6% (CPSC and Fisher-Price warn consumers about Fisher-Price Rock ‘N Play due to reports of death when infants roll over in the product) .
Analyst comments:
- LTHM -3% (downgraded to Neutral from Buy at Citigroup)
- NOK -3% (downgraded to Sell from Neutral at Goldman)
- CE -1.5% (downgraded to Hold from Buy at Deutsche Bank)
- WFC -1.2% (downgraded to Neutral at Goldman and removed from Conviction Buy List; also downgraded to Neutral from Buy at BofA/Merrill)
- ASML -1% (removed from Conviction Buy List at Goldman)
- PSX -0.9% (downgraded to Hold from Buy at Jefferies)
- AMT -0.7% (downgraded to Market Perform from Outperform at Wells Fargo)